Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA

Back

TGF Beta Inhibition for Cancer Therapy

Volume:6   Issue:7
Pp: 565-578
Elise F. Saunier and Rosemary J. Akhurst
DOI: 10.2174/156800906778742460

Order Reprints Order Eprints

Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models

Volume:6   Issue:7
Pp: 603-612
J. G. Hengstler, E. O. Bockamp, M. Hermes, M. Brulport, A. Bauer, W. Schormann, I. B. Schiffer, C. Hausherr, L. Eshkind, C. Antunes, A. Franzen, K. Krishnamurthi, E. Lausch, R. Lessig/snm, >, T. Chakrabarti, D. Prawitt, B. Zabel and C. Spangenberg
DOI: 10.2174/156800906778742488

Order Reprints Order Eprints

Five-Lipoxygenase Pathway of Arachidonic Acid Metabolism in Carcinogenesis and Cancer Chemoprevention

Volume:6   Issue:7
Pp: 613-622
Xiaoxin Chen, Sandeep Sood, Chung S. Yang, Ning Li and Zheng Sun
DOI: 10.2174/156800906778742451

Order Reprints Order Eprints

Protein Kinases as Drug Targets in Cancer

Volume:6   Issue:7
Pp: 623-634
Mehmet Alper Arslan, Ozgur Kutuk and Huveyda Basaga
DOI: 10.2174/156800906778742479

Order Reprints Order Eprints

Adrenomedullin: A Tumor Progression Factor via Angiogenic Control

Volume:6   Issue:7
Pp: 635-643
Misa Nakamura, Bo Han, Osamu Nunobiki and Kennichi Kakudo
DOI: 10.2174/156800906778742442

Order Reprints Order Eprints